Take a
proactive approach
to your vision

Take a proactive approach to your vision

When living with diabetic macular edema (DME), it’s important to make sure you’re doing what you can to stay on track with your treatment plan. DME is a chronic condition, but it may be possible to manage.

Caring for your vision

After treatment, it’s important to regularly check your vision for changes. If you experience any of the following symptoms or develop any change in vision, call your doctor right away:

Increased light sensitivity.

Increased light sensitivity

Light that has never bothered you before now bothers you.

Floaters.

Floaters

These may look like moving spots in your field of vision that persist or worsen.

Pain in your eye

Pain in your eye

Decrease in vision

Decrease in vision

This could be a decrease in your ability to see or the appearance of a veil in front of your vision.

Redness on white part of your eye

Redness on the white part of your eye

Download our posttreatment information guide for
more information.

Staying on treatment

Below are 3 ways to help take charge of your DME treatment:

Eating healthy can help lower your risk of developing wet age-related macular degeneration.

Stay on schedule with your appointments

Keeping a routine is important for DME. Create a plan that helps you prioritize your vision care and keep appointments.

Regular physical activity can help lower your risk of developing wet age-related macular degeneration.

Prepare for treatment days

Before your appointment, schedule transportation to and from treatment and prepare questions for your doctor.

If you smoke, quitting can significantly help lower your risk of developing wet age-related macular degeneration.

Monitor your vision

Keep track of any vision changes between appointments and alert your doctor if you notice anything unusual.

Keep up with your scheduled appointments and follow your doctor's guidance on your BEOVU treatment.

Text
size

Contrast

Back to Top Back to Top

INDICATIONS

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

COLLAPSE

EXPAND

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).

You should not use BEOVU if you have an infection in or around the eye, eye inflammation, or if you are allergic to brolucizumab or any of the ingredients in BEOVU.

BEOVU is a prescription medicine given by injection into the eye. Injections in the eye, including BEOVU, may cause an infection of the eye or retinal detachment (separation of retina from the back of the eye). It is important to contact your doctor right away if your eye becomes red, sensitive to light, painful, or you develop any change in your vision.

Increased eye pressure has been seen within 30 minutes of an eye injection, including BEOVU. Sustained increases in eye pressure also have been reported. Your doctor should monitor for this when you receive a BEOVU injection.

There is a potential risk of stroke, heart attack, or blood clots in patients receiving eye injections of vascular endothelial growth factor (VEGF) inhibitor drugs, including BEOVU. Sudden vision loss due to blockage of the blood vessels in the back of the eye and inflammation of blood vessels in the back of the eye have been reported.

The most common side effects reported in patients receiving BEOVU in the wet AMD studies were reduced clarity in vision, cataract, broken blood vessels in the eye, eye pain, and vitreous floaters (moving spots in the field of vision). The most common side effect reported in patients receiving BEOVU in the DME studies was broken blood vessels in the eye.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

Please see full Prescribing Information.

INDICATIONS

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).